MADRIGAL PHARMACEUTICALS, INC. Share Price
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Share Price of $9.02 per share as of 2012-12-31, per its 10-K filed 2013-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2013-03-14
- 2012-12-31: Share Price $9.02.
- 2012-07-31: Share Price $6.49.
- 2012-02-29: Share Price $4.40.
- 2012-01-31: Share Price $4.40.
| Period end | Share Price |
|---|---|
| 2012-12-31 | $9.02 10-K · filed 2013-03-14 |
| 2012-07-31 | $6.49 10-Q · filed 2012-11-06 |
| 2012-02-29 | $4.40 10-Q · filed 2012-11-06 |
| 2012-01-31 | $4.40 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |